St James’s Place PLC (LON:STJ) Rating Reaffirmed
London: In a note released on 27 November, Numis reiterated their Hold rating on St James’s Place PLC (LON:STJ) shares. They now have a GBX 1015.00 target price per share on the company. Numis’s target means a potential upside of 1.25% from the company’s current stock price.
From a total of 18 analysts covering St James’s Place PLC (LON:STJ) stock, 11 rate it a ”Buy”, 2 a “Sell”, and 5 a ”Hold”. This means that 61% of the ratings are positive. The highest target price is GBX 1141 while the lowest target price is GBX 1. The mean of all analyst targets is GBX 1036.14 with a 3.26% above today’s (GBX 1003.43) stock price. St James’s Place PLC was the topic of 46 analyst reports since July 23, 2015 according to the firm StockzIntelligence Inc. Numis Securities maintained shares on November 27 with “Hold” rating. Deutsche Bank maintained shares with “Buy” rating and GBX 980 target share price in a report from an October 28. JP Morgan maintained STJ stock in a recent report from November 23 with “Overweight” rating. Barclays Capital maintained the rating on October 28. Barclays Capital has a “Overweight” rating and a GBX 1100 price target on shares. Finally, Beaufort Securities maintained the stock with “Buy” rating in a report issued on an October 28.
The stock decreased 0.06% or GBX 0.57 on November 27, striking GBX 1003.43. Approximately 525,079 shares of stock traded hands. St. James’s Place plc (LON:STJ) has risen 13.88% since May 1, 2015 and is uptrending. It has outperformed by 14.77% the S&P500.
St. James’s Place plc is a United Kingdom parent firm of the St. The company has a market cap of 5.26 billion GBP. James’s Place Wealth Management Group, which provides wealth management advice, investment management and related services to businesses and individuals across the United Kingdom. It has 29.86 P/E ratio. The Firm operates in four divisions: Life, Unit Trust, Distribution and Other.
According to Zacks Investment Research, “St. Jude Medical, Inc. is dedicated to making life better for cardiac, neurological and chronic pain patients worldwide through excellence in medical device technology and services. The Company has five major focus areas that include cardiac rhythm management, atrial fibrillation, cardiac surgery, cardiology and neuromodulation.” Get a free copy of the Zacks research report on St. James’s Place plc (STJ)